Asian Annals Click here to go to Medistim website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Taweesak Chotivatanapong
Pradistchai Chaiseri
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chotivatanapong, T.
Right arrow Articles by Hengrussamee, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chotivatanapong, T.
Right arrow Articles by Hengrussamee, K.
Related Collections
Right arrow Valve disease
Asian Cardiovasc Thorac Ann 2005;13:321-324
© 2005 Asia Publishing EXchange Ltd


ORIGINAL CONTRIBUTION

Autologous Pericardial Valved Conduit for The Ross Operation

Taweesak Chotivatanapong, MD, Choosak Kasemsarn, MD, Chaiwuth Yosthasurodom, MD, Pradistchai Chaiseri, MD, Vibhan Sungkahapong, MD1, Kriengkrai Hengrussamee, MD2

Cardiothoracic Surgical Division
1 Division of Anesthesiology
2 Division of Cardiology, Chest Disease Institute Nonthaburi, Thailand

For reprint information contact: Taweesak Chotivatanapong, MD Tel: 66 2 588 3119 Fax: 66 2 589 9321 Email: taweesak13{at}hotmail.com, Department of Cardiothoracic Surgery, Chest Disease Institute, Tivanonth Rd, Nonthaburi 11000, Thailand.

The feasibility and function of autologous pericardial valved conduit for right ventricular outflow tract reconstruction in the Ross operation were assessed. Between June 1997 and April 2002, 31 patients underwent this procedure at our institution; one was lost to follow-up. The other 26 males and 4 females were aged 17 to 60 years (mean, 36.6 years). Causes of aortic valve disease were infective endocarditis in 26 and rheumatic valve disease in 4. Mean follow-up was 16.7 months (range, 1–58 months). Preoperatively, 9 patients were in functional class II, 19 in class III, and 2 in class IV. Concomitant procedures included coronary artery bypass (1), mitral valve replacement (6), tricuspid valve replacement (1), and ventricular septal defect closure (1). Mean aortic crossclamp time was 199.4 min. There were 4 (13.3%) hospital deaths and no late death. Mean postoperative functional class was 1.17 with +0.36 aortic regurgitation, a peak gradient of 21.9 mm Hg (range, 6–59 mm Hg) across the conduit, and grade +0.96 pulmonary regurgitation. No conduit-related complication was detected. Use of autologous valved conduit for the Ross operation is feasible. Long-term follow-up is mandatory to assess durability.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
W. A. Goetz, T. E. Tan, K. H. Lim, F. Xiong, S. L. H. Salgues, N. Grousson, Y. L. Chua, and J. H. Yeo
Autologous pericardial pulmonary conduit with single point attached commissures in a sheep model
Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 48 - 52.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. H. Yacoub
The Ross Operation - An Evolutionary Tale
Asian Cardiovasc Thorac Ann, February 1, 2006; 14(1): 1 - 2.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by the Asia Publishing EXchange Ltd.